nodes	percent_of_prediction	percent_of_DWPC	metapath
Plerixafor—CXCR4—Binding and entry of HIV virion—CD4—psoriasis	0.0416	0.189	CbGpPWpGaD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CCL20—psoriasis	0.0179	0.0817	CbGpPWpGaD
Plerixafor—CXCR4—Early Phase of HIV Life Cycle—CD4—psoriasis	0.0153	0.0695	CbGpPWpGaD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—CP—psoriasis	0.014	0.0638	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—HCAR2—psoriasis	0.011	0.0499	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	0.00872	0.0397	CbGpPWpGaD
Plerixafor—CXCR4—S1P3 pathway—VEGFA—psoriasis	0.0075	0.0342	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CCL20—psoriasis	0.00675	0.0307	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—HCAR2—psoriasis	0.00664	0.0302	CbGpPWpGaD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—LEP—psoriasis	0.0064	0.0291	CbGpPWpGaD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—NOS2—psoriasis	0.00596	0.0271	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—CCL20—psoriasis	0.0057	0.0259	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—HLA-DRB1—psoriasis	0.00516	0.0235	CbGpPWpGaD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CXCL8—psoriasis	0.00485	0.0221	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.00453	0.0206	CbGpPWpGaD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—JUN—psoriasis	0.00395	0.018	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—HCAR2—psoriasis	0.00375	0.0171	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—CD4—psoriasis	0.00364	0.0166	CbGpPWpGaD
Plerixafor—CXCR4—Hematopoietic Stem Cell Differentiation—IL6—psoriasis	0.00356	0.0162	CbGpPWpGaD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—VEGFA—psoriasis	0.00345	0.0157	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCL20—psoriasis	0.00345	0.0157	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—HCAR2—psoriasis	0.00341	0.0155	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—STAT3—psoriasis	0.00282	0.0128	CbGpPWpGaD
Plerixafor—CXCR4—HIV Infection—HLA-A—psoriasis	0.00265	0.0121	CbGpPWpGaD
Plerixafor—CXCR4—HIV Life Cycle—CD4—psoriasis	0.00248	0.0113	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HCAR2—psoriasis	0.00201	0.00916	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CCL20—psoriasis	0.00195	0.00887	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CXCL8—psoriasis	0.00182	0.0083	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCL20—psoriasis	0.00177	0.00806	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TAGAP—psoriasis	0.00175	0.00795	CbGpPWpGaD
Plerixafor—CXCR4—HIV Infection—CD4—psoriasis	0.00171	0.00778	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—CXCL8—psoriasis	0.00154	0.007	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.00122	0.00557	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCL20—psoriasis	0.00105	0.00476	CbGpPWpGaD
Plerixafor—Discomfort—Hydrocortisone—psoriasis	0.00102	0.00131	CcSEcCtD
Plerixafor—Connective tissue disorder—Prednisone—psoriasis	0.00102	0.00131	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.00101	0.0013	CcSEcCtD
Plerixafor—Anaphylactic shock—Prednisolone—psoriasis	0.00101	0.0013	CcSEcCtD
Plerixafor—Insomnia—Cyclosporine—psoriasis	0.00101	0.00129	CcSEcCtD
Plerixafor—Loss of consciousness—Triamcinolone—psoriasis	0.001	0.00129	CcSEcCtD
Plerixafor—Paraesthesia—Cyclosporine—psoriasis	0.001	0.00128	CcSEcCtD
Plerixafor—Shock—Prednisolone—psoriasis	0.000997	0.00128	CcSEcCtD
Plerixafor—Dyspnoea—Cyclosporine—psoriasis	0.000993	0.00127	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.00099	0.00127	CcSEcCtD
Plerixafor—Anaphylactic shock—Hydrocortisone—psoriasis	0.00099	0.00127	CcSEcCtD
Plerixafor—Asthenia—Mycophenolic acid—psoriasis	0.000988	0.00127	CcSEcCtD
Plerixafor—Insomnia—Mycophenolate mofetil—psoriasis	0.000983	0.00126	CcSEcCtD
Plerixafor—Dyspepsia—Cyclosporine—psoriasis	0.00098	0.00126	CcSEcCtD
Plerixafor—Hyperhidrosis—Prednisolone—psoriasis	0.00098	0.00126	CcSEcCtD
Plerixafor—Nausea—Hydroxyurea—psoriasis	0.000976	0.00125	CcSEcCtD
Plerixafor—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000975	0.00125	CcSEcCtD
Plerixafor—Pruritus—Mycophenolic acid—psoriasis	0.000974	0.00125	CcSEcCtD
Plerixafor—Shock—Hydrocortisone—psoriasis	0.000974	0.00125	CcSEcCtD
Plerixafor—Nervous system disorder—Hydrocortisone—psoriasis	0.000971	0.00124	CcSEcCtD
Plerixafor—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000969	0.00124	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000961	0.00123	CcSEcCtD
Plerixafor—Skin disorder—Hydrocortisone—psoriasis	0.000961	0.00123	CcSEcCtD
Plerixafor—Ill-defined disorder—Dexamethasone—psoriasis	0.000961	0.00123	CcSEcCtD
Plerixafor—Ill-defined disorder—Betamethasone—psoriasis	0.000961	0.00123	CcSEcCtD
Plerixafor—Discomfort—Triamcinolone—psoriasis	0.00096	0.00123	CcSEcCtD
Plerixafor—Fatigue—Cyclosporine—psoriasis	0.00096	0.00123	CcSEcCtD
Plerixafor—Hyperhidrosis—Hydrocortisone—psoriasis	0.000957	0.00123	CcSEcCtD
Plerixafor—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000956	0.00123	CcSEcCtD
Plerixafor—Pain—Cyclosporine—psoriasis	0.000952	0.00122	CcSEcCtD
Plerixafor—Constipation—Cyclosporine—psoriasis	0.000952	0.00122	CcSEcCtD
Plerixafor—Dry mouth—Triamcinolone—psoriasis	0.000951	0.00122	CcSEcCtD
Plerixafor—Diarrhoea—Mycophenolic acid—psoriasis	0.000942	0.00121	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000938	0.0012	CcSEcCtD
Plerixafor—Immune system disorder—Prednisone—psoriasis	0.000936	0.0012	CcSEcCtD
Plerixafor—Malaise—Dexamethasone—psoriasis	0.000934	0.0012	CcSEcCtD
Plerixafor—Malaise—Betamethasone—psoriasis	0.000934	0.0012	CcSEcCtD
Plerixafor—Anaphylactic shock—Triamcinolone—psoriasis	0.000932	0.0012	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—CXCL8—psoriasis	0.000932	0.00424	CbGpPWpGaD
Plerixafor—Syncope—Dexamethasone—psoriasis	0.000929	0.00119	CcSEcCtD
Plerixafor—Syncope—Betamethasone—psoriasis	0.000929	0.00119	CcSEcCtD
Plerixafor—Constipation—Mycophenolate mofetil—psoriasis	0.000929	0.00119	CcSEcCtD
Plerixafor—Pain—Mycophenolate mofetil—psoriasis	0.000929	0.00119	CcSEcCtD
Plerixafor—Feeling abnormal—Cyclosporine—psoriasis	0.000918	0.00118	CcSEcCtD
Plerixafor—Shock—Triamcinolone—psoriasis	0.000917	0.00118	CcSEcCtD
Plerixafor—Insomnia—Prednisolone—psoriasis	0.000917	0.00118	CcSEcCtD
Plerixafor—Gastrointestinal pain—Cyclosporine—psoriasis	0.000911	0.00117	CcSEcCtD
Plerixafor—Loss of consciousness—Betamethasone—psoriasis	0.000911	0.00117	CcSEcCtD
Plerixafor—Loss of consciousness—Dexamethasone—psoriasis	0.000911	0.00117	CcSEcCtD
Plerixafor—Dizziness—Mycophenolic acid—psoriasis	0.00091	0.00117	CcSEcCtD
Plerixafor—Paraesthesia—Prednisolone—psoriasis	0.00091	0.00117	CcSEcCtD
Plerixafor—Mental disorder—Prednisone—psoriasis	0.000908	0.00116	CcSEcCtD
Plerixafor—Erythema—Prednisone—psoriasis	0.000902	0.00116	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000902	0.00116	CcSEcCtD
Plerixafor—Hyperhidrosis—Triamcinolone—psoriasis	0.000901	0.00116	CcSEcCtD
Plerixafor—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000895	0.00115	CcSEcCtD
Plerixafor—Insomnia—Hydrocortisone—psoriasis	0.000895	0.00115	CcSEcCtD
Plerixafor—Paraesthesia—Hydrocortisone—psoriasis	0.000889	0.00114	CcSEcCtD
Plerixafor—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000888	0.00114	CcSEcCtD
Plerixafor—Urticaria—Cyclosporine—psoriasis	0.000885	0.00113	CcSEcCtD
Plerixafor—Abdominal pain—Cyclosporine—psoriasis	0.00088	0.00113	CcSEcCtD
Plerixafor—Vomiting—Mycophenolic acid—psoriasis	0.000875	0.00112	CcSEcCtD
Plerixafor—Discomfort—Dexamethasone—psoriasis	0.000871	0.00112	CcSEcCtD
Plerixafor—Discomfort—Betamethasone—psoriasis	0.000871	0.00112	CcSEcCtD
Plerixafor—Dyspepsia—Hydrocortisone—psoriasis	0.000871	0.00112	CcSEcCtD
Plerixafor—Haemoglobin—Methotrexate—psoriasis	0.000871	0.00112	CcSEcCtD
Plerixafor—Rash—Mycophenolic acid—psoriasis	0.000868	0.00111	CcSEcCtD
Plerixafor—Dermatitis—Mycophenolic acid—psoriasis	0.000867	0.00111	CcSEcCtD
Plerixafor—Pain—Prednisolone—psoriasis	0.000867	0.00111	CcSEcCtD
Plerixafor—Haemorrhage—Methotrexate—psoriasis	0.000866	0.00111	CcSEcCtD
Plerixafor—Urticaria—Mycophenolate mofetil—psoriasis	0.000863	0.00111	CcSEcCtD
Plerixafor—Headache—Mycophenolic acid—psoriasis	0.000862	0.00111	CcSEcCtD
Plerixafor—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000859	0.0011	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000854	0.0011	CcSEcCtD
Plerixafor—Fatigue—Hydrocortisone—psoriasis	0.000853	0.00109	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000849	0.00109	CcSEcCtD
Plerixafor—Pain—Hydrocortisone—psoriasis	0.000846	0.00109	CcSEcCtD
Plerixafor—Anaphylactic shock—Dexamethasone—psoriasis	0.000846	0.00108	CcSEcCtD
Plerixafor—Anaphylactic shock—Betamethasone—psoriasis	0.000846	0.00108	CcSEcCtD
Plerixafor—Insomnia—Triamcinolone—psoriasis	0.000843	0.00108	CcSEcCtD
Plerixafor—Ill-defined disorder—Prednisone—psoriasis	0.000837	0.00107	CcSEcCtD
Plerixafor—Paraesthesia—Triamcinolone—psoriasis	0.000837	0.00107	CcSEcCtD
Plerixafor—Feeling abnormal—Prednisolone—psoriasis	0.000835	0.00107	CcSEcCtD
Plerixafor—Shock—Dexamethasone—psoriasis	0.000832	0.00107	CcSEcCtD
Plerixafor—Shock—Betamethasone—psoriasis	0.000832	0.00107	CcSEcCtD
Plerixafor—Dyspnoea—Triamcinolone—psoriasis	0.000831	0.00107	CcSEcCtD
Plerixafor—Nervous system disorder—Dexamethasone—psoriasis	0.000829	0.00106	CcSEcCtD
Plerixafor—Nervous system disorder—Betamethasone—psoriasis	0.000829	0.00106	CcSEcCtD
Plerixafor—Hypersensitivity—Cyclosporine—psoriasis	0.00082	0.00105	CcSEcCtD
Plerixafor—Dyspepsia—Triamcinolone—psoriasis	0.00082	0.00105	CcSEcCtD
Plerixafor—Nausea—Mycophenolic acid—psoriasis	0.000818	0.00105	CcSEcCtD
Plerixafor—Hyperhidrosis—Dexamethasone—psoriasis	0.000817	0.00105	CcSEcCtD
Plerixafor—Hyperhidrosis—Betamethasone—psoriasis	0.000817	0.00105	CcSEcCtD
Plerixafor—Feeling abnormal—Hydrocortisone—psoriasis	0.000816	0.00105	CcSEcCtD
Plerixafor—Malaise—Prednisone—psoriasis	0.000814	0.00104	CcSEcCtD
Plerixafor—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000809	0.00104	CcSEcCtD
Plerixafor—Syncope—Prednisone—psoriasis	0.000809	0.00104	CcSEcCtD
Plerixafor—Urticaria—Prednisolone—psoriasis	0.000805	0.00103	CcSEcCtD
Plerixafor—Fatigue—Triamcinolone—psoriasis	0.000803	0.00103	CcSEcCtD
Plerixafor—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.0008	0.00103	CcSEcCtD
Plerixafor—Asthenia—Cyclosporine—psoriasis	0.000799	0.00102	CcSEcCtD
Plerixafor—Pain—Triamcinolone—psoriasis	0.000797	0.00102	CcSEcCtD
Plerixafor—Loss of consciousness—Prednisone—psoriasis	0.000793	0.00102	CcSEcCtD
Plerixafor—Pruritus—Cyclosporine—psoriasis	0.000788	0.00101	CcSEcCtD
Plerixafor—Urticaria—Hydrocortisone—psoriasis	0.000786	0.00101	CcSEcCtD
Plerixafor—Immune system disorder—Methotrexate—psoriasis	0.000782	0.001	CcSEcCtD
Plerixafor—Abdominal pain—Hydrocortisone—psoriasis	0.000782	0.001	CcSEcCtD
Plerixafor—Asthenia—Mycophenolate mofetil—psoriasis	0.000779	0.001	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Betamethasone—psoriasis	0.00077	0.000988	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.00077	0.000988	CcSEcCtD
Plerixafor—Pruritus—Mycophenolate mofetil—psoriasis	0.000769	0.000986	CcSEcCtD
Plerixafor—Arthralgia—Prednisone—psoriasis	0.000768	0.000985	CcSEcCtD
Plerixafor—Feeling abnormal—Triamcinolone—psoriasis	0.000768	0.000985	CcSEcCtD
Plerixafor—Insomnia—Dexamethasone—psoriasis	0.000765	0.000981	CcSEcCtD
Plerixafor—Insomnia—Betamethasone—psoriasis	0.000765	0.000981	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000763	0.000978	CcSEcCtD
Plerixafor—Diarrhoea—Cyclosporine—psoriasis	0.000762	0.000977	CcSEcCtD
Plerixafor—Paraesthesia—Dexamethasone—psoriasis	0.000759	0.000974	CcSEcCtD
Plerixafor—Paraesthesia—Betamethasone—psoriasis	0.000759	0.000974	CcSEcCtD
Plerixafor—Discomfort—Prednisone—psoriasis	0.000759	0.000973	CcSEcCtD
Plerixafor—Mental disorder—Methotrexate—psoriasis	0.000759	0.000973	CcSEcCtD
Plerixafor—Erythema—Methotrexate—psoriasis	0.000754	0.000967	CcSEcCtD
Plerixafor—Hypersensitivity—Prednisolone—psoriasis	0.000747	0.000958	CcSEcCtD
Plerixafor—Dyspepsia—Betamethasone—psoriasis	0.000744	0.000955	CcSEcCtD
Plerixafor—Dyspepsia—Dexamethasone—psoriasis	0.000744	0.000955	CcSEcCtD
Plerixafor—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000743	0.000953	CcSEcCtD
Plerixafor—Urticaria—Triamcinolone—psoriasis	0.00074	0.000949	CcSEcCtD
Plerixafor—Dizziness—Cyclosporine—psoriasis	0.000736	0.000944	CcSEcCtD
Plerixafor—Anaphylactic shock—Prednisone—psoriasis	0.000736	0.000944	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Betamethasone—psoriasis	0.00073	0.000936	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Dexamethasone—psoriasis	0.00073	0.000936	CcSEcCtD
Plerixafor—Hypersensitivity—Hydrocortisone—psoriasis	0.000729	0.000935	CcSEcCtD
Plerixafor—Fatigue—Dexamethasone—psoriasis	0.000729	0.000935	CcSEcCtD
Plerixafor—Fatigue—Betamethasone—psoriasis	0.000729	0.000935	CcSEcCtD
Plerixafor—Shock—Prednisone—psoriasis	0.000724	0.000929	CcSEcCtD
Plerixafor—Pain—Betamethasone—psoriasis	0.000723	0.000927	CcSEcCtD
Plerixafor—Pain—Dexamethasone—psoriasis	0.000723	0.000927	CcSEcCtD
Plerixafor—Nervous system disorder—Prednisone—psoriasis	0.000722	0.000926	CcSEcCtD
Plerixafor—Dizziness—Mycophenolate mofetil—psoriasis	0.000718	0.000921	CcSEcCtD
Plerixafor—Skin disorder—Prednisone—psoriasis	0.000715	0.000917	CcSEcCtD
Plerixafor—Hyperhidrosis—Prednisone—psoriasis	0.000712	0.000913	CcSEcCtD
Plerixafor—Asthenia—Hydrocortisone—psoriasis	0.00071	0.000911	CcSEcCtD
Plerixafor—Vomiting—Cyclosporine—psoriasis	0.000708	0.000908	CcSEcCtD
Plerixafor—Rash—Cyclosporine—psoriasis	0.000702	0.000901	CcSEcCtD
Plerixafor—Dermatitis—Cyclosporine—psoriasis	0.000702	0.0009	CcSEcCtD
Plerixafor—Pruritus—Hydrocortisone—psoriasis	0.0007	0.000898	CcSEcCtD
Plerixafor—Ill-defined disorder—Methotrexate—psoriasis	0.0007	0.000897	CcSEcCtD
Plerixafor—Headache—Cyclosporine—psoriasis	0.000698	0.000895	CcSEcCtD
Plerixafor—Feeling abnormal—Dexamethasone—psoriasis	0.000697	0.000894	CcSEcCtD
Plerixafor—Feeling abnormal—Betamethasone—psoriasis	0.000697	0.000894	CcSEcCtD
Plerixafor—Gastrointestinal pain—Dexamethasone—psoriasis	0.000691	0.000887	CcSEcCtD
Plerixafor—Gastrointestinal pain—Betamethasone—psoriasis	0.000691	0.000887	CcSEcCtD
Plerixafor—Vomiting—Mycophenolate mofetil—psoriasis	0.000691	0.000886	CcSEcCtD
Plerixafor—Hypersensitivity—Triamcinolone—psoriasis	0.000687	0.000881	CcSEcCtD
Plerixafor—Rash—Mycophenolate mofetil—psoriasis	0.000685	0.000878	CcSEcCtD
Plerixafor—Dermatitis—Mycophenolate mofetil—psoriasis	0.000684	0.000878	CcSEcCtD
Plerixafor—Headache—Mycophenolate mofetil—psoriasis	0.000681	0.000873	CcSEcCtD
Plerixafor—Malaise—Methotrexate—psoriasis	0.00068	0.000872	CcSEcCtD
Plerixafor—Diarrhoea—Hydrocortisone—psoriasis	0.000677	0.000868	CcSEcCtD
Plerixafor—Urticaria—Dexamethasone—psoriasis	0.000672	0.000861	CcSEcCtD
Plerixafor—Urticaria—Betamethasone—psoriasis	0.000672	0.000861	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Prednisone—psoriasis	0.000671	0.00086	CcSEcCtD
Plerixafor—Dizziness—Prednisolone—psoriasis	0.00067	0.000859	CcSEcCtD
Plerixafor—Asthenia—Triamcinolone—psoriasis	0.000669	0.000857	CcSEcCtD
Plerixafor—Abdominal pain—Dexamethasone—psoriasis	0.000668	0.000857	CcSEcCtD
Plerixafor—Abdominal pain—Betamethasone—psoriasis	0.000668	0.000857	CcSEcCtD
Plerixafor—Insomnia—Prednisone—psoriasis	0.000666	0.000854	CcSEcCtD
Plerixafor—Nausea—Cyclosporine—psoriasis	0.000661	0.000848	CcSEcCtD
Plerixafor—Paraesthesia—Prednisone—psoriasis	0.000661	0.000848	CcSEcCtD
Plerixafor—Pruritus—Triamcinolone—psoriasis	0.000659	0.000846	CcSEcCtD
Plerixafor—Dizziness—Hydrocortisone—psoriasis	0.000654	0.000839	CcSEcCtD
Plerixafor—CXCR4—Disease—HLA-A—psoriasis	0.00065	0.00296	CbGpPWpGaD
Plerixafor—Dyspepsia—Prednisone—psoriasis	0.000648	0.000831	CcSEcCtD
Plerixafor—Nausea—Mycophenolate mofetil—psoriasis	0.000645	0.000828	CcSEcCtD
Plerixafor—Arthralgia—Methotrexate—psoriasis	0.000642	0.000823	CcSEcCtD
Plerixafor—Rash—Prednisolone—psoriasis	0.000639	0.000819	CcSEcCtD
Plerixafor—Dermatitis—Prednisolone—psoriasis	0.000638	0.000819	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000638	0.000818	CcSEcCtD
Plerixafor—Fatigue—Prednisone—psoriasis	0.000635	0.000814	CcSEcCtD
Plerixafor—Headache—Prednisolone—psoriasis	0.000635	0.000814	CcSEcCtD
Plerixafor—Discomfort—Methotrexate—psoriasis	0.000634	0.000813	CcSEcCtD
Plerixafor—Constipation—Prednisone—psoriasis	0.00063	0.000808	CcSEcCtD
Plerixafor—Vomiting—Hydrocortisone—psoriasis	0.000629	0.000807	CcSEcCtD
Plerixafor—Rash—Hydrocortisone—psoriasis	0.000624	0.0008	CcSEcCtD
Plerixafor—Dermatitis—Hydrocortisone—psoriasis	0.000623	0.0008	CcSEcCtD
Plerixafor—Headache—Hydrocortisone—psoriasis	0.00062	0.000795	CcSEcCtD
Plerixafor—Dizziness—Triamcinolone—psoriasis	0.000616	0.00079	CcSEcCtD
Plerixafor—Anaphylactic shock—Methotrexate—psoriasis	0.000615	0.000789	CcSEcCtD
Plerixafor—CXCR4—Disease—APOE—psoriasis	0.000607	0.00276	CbGpPWpGaD
Plerixafor—Feeling abnormal—Prednisone—psoriasis	0.000607	0.000778	CcSEcCtD
Plerixafor—Asthenia—Dexamethasone—psoriasis	0.000607	0.000778	CcSEcCtD
Plerixafor—Asthenia—Betamethasone—psoriasis	0.000607	0.000778	CcSEcCtD
Plerixafor—Nervous system disorder—Methotrexate—psoriasis	0.000604	0.000774	CcSEcCtD
Plerixafor—Gastrointestinal pain—Prednisone—psoriasis	0.000602	0.000772	CcSEcCtD
Plerixafor—Nausea—Prednisolone—psoriasis	0.000602	0.000772	CcSEcCtD
Plerixafor—Pruritus—Betamethasone—psoriasis	0.000598	0.000767	CcSEcCtD
Plerixafor—Pruritus—Dexamethasone—psoriasis	0.000598	0.000767	CcSEcCtD
Plerixafor—Skin disorder—Methotrexate—psoriasis	0.000598	0.000767	CcSEcCtD
Plerixafor—Hyperhidrosis—Methotrexate—psoriasis	0.000595	0.000763	CcSEcCtD
Plerixafor—Vomiting—Triamcinolone—psoriasis	0.000593	0.00076	CcSEcCtD
Plerixafor—Nausea—Hydrocortisone—psoriasis	0.000588	0.000754	CcSEcCtD
Plerixafor—Rash—Triamcinolone—psoriasis	0.000588	0.000754	CcSEcCtD
Plerixafor—Dermatitis—Triamcinolone—psoriasis	0.000587	0.000753	CcSEcCtD
Plerixafor—Urticaria—Prednisone—psoriasis	0.000585	0.00075	CcSEcCtD
Plerixafor—Headache—Triamcinolone—psoriasis	0.000584	0.000749	CcSEcCtD
Plerixafor—Abdominal pain—Prednisone—psoriasis	0.000582	0.000747	CcSEcCtD
Plerixafor—Diarrhoea—Betamethasone—psoriasis	0.000579	0.000742	CcSEcCtD
Plerixafor—Diarrhoea—Dexamethasone—psoriasis	0.000579	0.000742	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—SOCS1—psoriasis	0.000576	0.00262	CbGpPWpGaD
Plerixafor—CXCR4—Disease—NOS2—psoriasis	0.000566	0.00257	CbGpPWpGaD
Plerixafor—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000561	0.000719	CcSEcCtD
Plerixafor—Dizziness—Dexamethasone—psoriasis	0.000559	0.000717	CcSEcCtD
Plerixafor—Dizziness—Betamethasone—psoriasis	0.000559	0.000717	CcSEcCtD
Plerixafor—Insomnia—Methotrexate—psoriasis	0.000557	0.000714	CcSEcCtD
Plerixafor—Nausea—Triamcinolone—psoriasis	0.000554	0.00071	CcSEcCtD
Plerixafor—Paraesthesia—Methotrexate—psoriasis	0.000553	0.000709	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—TYK2—psoriasis	0.000549	0.0025	CbGpPWpGaD
Plerixafor—Dyspnoea—Methotrexate—psoriasis	0.000549	0.000704	CcSEcCtD
Plerixafor—Hypersensitivity—Prednisone—psoriasis	0.000543	0.000696	CcSEcCtD
Plerixafor—Dyspepsia—Methotrexate—psoriasis	0.000542	0.000695	CcSEcCtD
Plerixafor—Vomiting—Dexamethasone—psoriasis	0.000538	0.000689	CcSEcCtD
Plerixafor—Vomiting—Betamethasone—psoriasis	0.000538	0.000689	CcSEcCtD
Plerixafor—Rash—Dexamethasone—psoriasis	0.000533	0.000684	CcSEcCtD
Plerixafor—Rash—Betamethasone—psoriasis	0.000533	0.000684	CcSEcCtD
Plerixafor—Dermatitis—Betamethasone—psoriasis	0.000533	0.000683	CcSEcCtD
Plerixafor—Dermatitis—Dexamethasone—psoriasis	0.000533	0.000683	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Methotrexate—psoriasis	0.000531	0.000681	CcSEcCtD
Plerixafor—Fatigue—Methotrexate—psoriasis	0.000531	0.00068	CcSEcCtD
Plerixafor—Headache—Dexamethasone—psoriasis	0.00053	0.000679	CcSEcCtD
Plerixafor—Headache—Betamethasone—psoriasis	0.00053	0.000679	CcSEcCtD
Plerixafor—Asthenia—Prednisone—psoriasis	0.000528	0.000678	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—CXCL8—psoriasis	0.000526	0.0024	CbGpPWpGaD
Plerixafor—Pain—Methotrexate—psoriasis	0.000526	0.000675	CcSEcCtD
Plerixafor—Pruritus—Prednisone—psoriasis	0.000521	0.000668	CcSEcCtD
Plerixafor—Feeling abnormal—Methotrexate—psoriasis	0.000507	0.00065	CcSEcCtD
Plerixafor—Diarrhoea—Prednisone—psoriasis	0.000504	0.000646	CcSEcCtD
Plerixafor—Gastrointestinal pain—Methotrexate—psoriasis	0.000503	0.000645	CcSEcCtD
Plerixafor—Nausea—Betamethasone—psoriasis	0.000502	0.000644	CcSEcCtD
Plerixafor—Nausea—Dexamethasone—psoriasis	0.000502	0.000644	CcSEcCtD
Plerixafor—Urticaria—Methotrexate—psoriasis	0.000489	0.000627	CcSEcCtD
Plerixafor—Dizziness—Prednisone—psoriasis	0.000487	0.000625	CcSEcCtD
Plerixafor—Abdominal pain—Methotrexate—psoriasis	0.000487	0.000624	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CXCL8—psoriasis	0.000478	0.00218	CbGpPWpGaD
Plerixafor—Vomiting—Prednisone—psoriasis	0.000468	0.0006	CcSEcCtD
Plerixafor—Rash—Prednisone—psoriasis	0.000464	0.000595	CcSEcCtD
Plerixafor—Dermatitis—Prednisone—psoriasis	0.000464	0.000595	CcSEcCtD
Plerixafor—CXCR4—Disease—TYK2—psoriasis	0.000463	0.00211	CbGpPWpGaD
Plerixafor—Headache—Prednisone—psoriasis	0.000461	0.000592	CcSEcCtD
Plerixafor—Hypersensitivity—Methotrexate—psoriasis	0.000453	0.000581	CcSEcCtD
Plerixafor—Asthenia—Methotrexate—psoriasis	0.000442	0.000566	CcSEcCtD
Plerixafor—Nausea—Prednisone—psoriasis	0.000437	0.000561	CcSEcCtD
Plerixafor—Pruritus—Methotrexate—psoriasis	0.000435	0.000558	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—LEP—psoriasis	0.000425	0.00193	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—APOE—psoriasis	0.000425	0.00193	CbGpPWpGaD
Plerixafor—Diarrhoea—Methotrexate—psoriasis	0.000421	0.00054	CcSEcCtD
Plerixafor—CXCR4—Disease—CD4—psoriasis	0.000419	0.00191	CbGpPWpGaD
Plerixafor—Dizziness—Methotrexate—psoriasis	0.000407	0.000522	CcSEcCtD
Plerixafor—CXCR4—endothelium—psoriasis	0.000406	0.755	CbGeAlD
Plerixafor—CXCR4—Signaling Pathways—NFKBIA—psoriasis	0.000396	0.0018	CbGpPWpGaD
Plerixafor—Vomiting—Methotrexate—psoriasis	0.000391	0.000502	CcSEcCtD
Plerixafor—Rash—Methotrexate—psoriasis	0.000388	0.000498	CcSEcCtD
Plerixafor—Dermatitis—Methotrexate—psoriasis	0.000388	0.000497	CcSEcCtD
Plerixafor—Headache—Methotrexate—psoriasis	0.000386	0.000494	CcSEcCtD
Plerixafor—Nausea—Methotrexate—psoriasis	0.000366	0.000469	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—TYK2—psoriasis	0.000324	0.00148	CbGpPWpGaD
Plerixafor—CXCR4—Disease—STAT3—psoriasis	0.000324	0.00148	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CXCL8—psoriasis	0.000282	0.00129	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—IL6—psoriasis	0.000269	0.00122	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—JUN—psoriasis	0.000263	0.0012	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NFKB1—psoriasis	0.000253	0.00115	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—VEGFA—psoriasis	0.000229	0.00104	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—STAT3—psoriasis	0.000227	0.00103	CbGpPWpGaD
Plerixafor—CXCR4—Disease—IL6—psoriasis	0.000227	0.00103	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TP53—psoriasis	0.000173	0.000789	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IL6—psoriasis	0.000159	0.000722	CbGpPWpGaD
Plerixafor—CXCR4—tendon—psoriasis	0.000132	0.245	CbGeAlD
